A Phase II study of M528101 for postherpetic neuralgia
Phase 2
Recruiting
- Conditions
- Postherpetic neuralgia
- Registration Number
- JPRN-jRCT2031220415
- Lead Sponsor
- Tomoyuki Nishiura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Postherpetic neuralgia patients aged 18 years and older
Exclusion Criteria
(1)Patients with herpes zoster skin symptoms (edematous erythema, blisters, erosions, crusts) or other epidermal abrasions (erosions, ulcers, fissures) at the drug administration site (postherpetic neuralgia expression site)
(2)Patients with symptoms or treatment history (including neurodestructive drugs and radiofrequency thermocoagulation) that the investigator (subinvestigator) judges may affect the pain NRS evaluation of postherpetic neuralgia
(3)Patients who have or are currently undergoing drug treatment with opioids for postherpetic neuralgia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method